Abiopharma

🔍 Winn Walter Timothy (Executive)

Company: Southland Holdings, Inc. (SLND)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 15,706 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,992,952.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 15,706 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,706.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit is equivalent to one share of the Issuer's common stock.
• F2: The reporting person received an award of 47,118 restricted stock units ("RSUs") on June 25, 2024. The RSUs vest over a three-year period, with one-third (1/3) of the RSUs having vested on June 25, 2025, one-third (1/3) of the RSUs having vested on June 25, 2026, and the remaining one-third (1/3) of the RSUs vesting on June 25, 2027.